# pyrazinamide = z

### notes
+ prescription under medical supervision

### therapeutic action

+ first line antituberculous antibacterial (sterilising and bactericidal activity)

### indications
+ tuberculosis, in combination with other antituberculous antibacterials

### presentation
+ 400 mg tablet

### dosage
+ child under 30 kg: 35 mg/kg (30 to 40 mg/kg/day) once daily
+ child over 30 kg and adult: 25 mg/kg (20 to 30 mg/kg/day) once daily
+ maximum dose: 2 g/day

### duration
+ according to protocol

### contra-indications, adverse effects, precautions
+ do not administer to patients with hypersensitivity to pyrazinamide, severe hepatic impairment or severe gout.
+ reduce the dose in patients with renal impairment (25 mg/kg/dose 3 times per week).
+ may cause: gout and arthralgias, hepatic disorders (jaundice), photosensitivity (limit sun exposure), rash, gastrointestinal disturbances, hypersensitivity reactions.
+ if signs of hepatotoxicity (e.g. jaundice) develop, pyrazinamide should be discontinued until symptoms resolve.
+ *pregnancy*: safety of pyrazinamide in the first trimester is not definitely established. however, given the severity of the disease, it may be used during pregnancy.
+ *breast-feeding*: no contra-indication

### remarks
+ for patients on first-line antituberculous treatment, pyrazinamide is given as part of a fixed dose combination (isoniazid+rifampicin+pyrazinamide+ethambutol or isoniazid+ rifampicin+ pyrazinamide).
+ storage: below 25Â°c

